The Gwent AST project has accurately identified patients at risk of advanced liver disease using an AST:ALT ratio performed by GPs (Yeomanet al., 2020) and our POU test would take the AST:ALT ratio out of primary care, bringing it into the community, thus enabling cost-effective screening and identification of at-risk populations. Here, GPT is linked to liver disorder.